Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.12%
1,054.77
-1.31
-0.12%
—1,056.081,055.451,056.151,044.14——
SIXC
Communications
SIXC
Communications
SIXC
-0.18%
605.83
-1.07
-0.18%
—606.90606.90606.90601.25——
SIXE
Energy
SIXE
Energy
SIXE
-0.14%
1,249.94
-1.77
-0.14%
—1,251.711,264.021,267.841,248.95——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.72%
1,708.29
-12.35
-0.72%
—1,720.641,717.521,717.521,702.65——
SIXM
Financials
SIXM
Financials
SIXM
-0.17%
634.91
-1.10
-0.17%
—636.01635.43637.14630.76——
SIXR
Staples
SIXR
Staples
SIXR
-1.39%
849.94
-11.94
-1.39%
—861.88854.93854.93841.82——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.19%
217.66
-0.42
-0.19%
—218.08218.08218.08215.77——
SIXT
Technology
SIXT
Technology
SIXT
-0.13%
3,562.29
-4.68
-0.13%
—3,566.973,549.543,586.313,543.40——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.64%
905.03
+5.76
+0.64%
—899.27900.59906.42897.62——
SIXV
Health care
SIXV
Health care
SIXV
+0.19%
1,488.23
+2.76
+0.19%
—1,485.471,483.471,488.921,472.99——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.35%
2,374.67
-8.39
-0.35%
—2,383.062,381.252,381.252,360.53——
FLNA:NASDAQ
Filana Therapeutics Inc
$1.26
+0.80%
(+0.0100) 1D
May 21, 11:13:56 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for FLNA...
Open
$1.25
High
$1.26
Low
$1.22
Mkt. cap
60.63M
Avg. vol.
412.06K
Volume
42.70K
52-wk high
$2.27
52-wk low
$1.16
EPS
-$1.61
Beta
-0.74
Shares outstanding
48.31M
No. of employees
19
News stories
From sources across the web
Profile
Filana Therapeutics, Inc. is an American pharmaceutical company based in Austin, Texas. The company was developing simufilam, an oral-tablet drug candidate for the treatment of Alzheimer's disease. Development of simufilam was discontinued in November 2024 after it failed to show clinical benefit in phase III clinical trials. In June 2024, the United States Department of Justice charged an advisor to company, Hoau-Yan Wang, with fraud over research results related to the experimental drug. Less than a month later, the president, chief executive officer and chairman of the board, Remi Barbier, resigned along with Lindsay Burns, his wife, who was the company's senior vice president and Wang's co-author. The U.S. Securities and Exchange Commission filed fraud charges in September 2024 against Barbier, Burns and Wang. The parties did not admit wrongdoing, but agreed to pay fines of the company $40 million, Barbier $175,000, Burns $85,000, and Wang $50,000. The DOJ dropped the fraud charges against Wang shortly before trial was scheduled to begin in October 2025 without giving a reason. Wikipedia
About Filana Therapeutics Inc
CEO-
Employees19
Founded1998
HeadquartersAustin, Texas, United States
SectorPharmaceutical industry
Website-
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
5.12M
3.96M
3.85M
-
Cost of revenue
5.12M
3.96M
3.85M
-
Research and development expenses
-
-
-
4.54M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.98M
7.90M
5.70M
6.62M
Operating expense
8.98M
7.90M
5.70M
11.17M
Total operating expenses
14.09M
11.86M
9.55M
11.17M
Operating income
-14.09M
-11.86M
-9.55M
-11.17M
Other non operating income
-46.00K
-114.00K
39.00K
48.00K
EBT including unusual items
-44.22M
-10.81M
-12.54M
-10.33M
EBT excluding unusual items
-12.92M
-10.81M
-8.54M
-10.33M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-44.22M
-10.81M
-12.54M
-10.33M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
1.21M
1.17M
974.00K
789.00K
Interest expense
-
-
-
-
Net interest expenses
1.21M
1.17M
974.00K
789.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-13.87M
-11.73M
-9.18M
-10.93M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer